Literature DB >> 2649258

Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis.

C E Wilcox1, D Baker, C Butter, D A Willoughby, J L Turk.   

Abstract

Previous studies have shown that vascular endothelial cells do not normally express major histocompatibility complex (MHC) Class II antigens either in vivo or in vitro. In this investigation it was found that endothelial in the central nervous system (CNS) of normal guinea pigs constitutively express MHC Class II antigens recognized by the monoclonal antibodies HLA-DR, 27E7, and MSgp8. This phenotype is retained when these CNS-derived endothelial cells are propagated in tissue culture. Furthermore, examination of CNS tissue taken from animals in the acute phase of chronic relapsing experimental allergic encephalomyelitis shows that additional epitopes of the MHC Class II antigen, detected by the monoclonal antibodies CI.13.1 and 22C4, are present during the diseased state. This study not only demonstrates constitutive expression of certain MHC Class II determinants by guinea pig endothelial cells, but also shows that other Class II determinants can be differentially expressed in certain disease states.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649258     DOI: 10.1016/0008-8749(89)90176-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

3.  Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis.

Authors:  C E Wilcox; D G Healey; D Baker; D A Willoughby; J L Turk
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

4.  Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system.

Authors:  K Vass; H Lassmann
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Authors:  Diane J Ordway; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Daniel S Bucy; Laurel Hascall-Dove; Marcela Henao-Tamayo; Marisa R Harton; Shaobin Shang; David Ackart; Susan L Kraft; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

6.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

7.  Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells.

Authors:  H K Huynh; K Dorovini-Zis
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Post-exposure vaccination against Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Gopinath S Palaniswamy; Erin E Smith; Crystal A Shanley; Baolin Wang; Ian M Orme; Randall J Basaraba; Nancy M DuTeau; Diane Ordway
Journal:  Tuberculosis (Edinb)       Date:  2009-03-04       Impact factor: 3.131

9.  Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Crystal Shanley; Erin E Smith; Gopinath Palanisamy; Baolin Wang; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2008-05-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.